Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like Meet Man in the Lab at the March 6, 2017 Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue July 27, 2017 Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics December 3, 2017
Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics December 3, 2017
